Robby Nieuwlaat

Summary

Affiliation: University Hospital Maastricht
Country: The Netherlands

Publications

  1. ncbi [Treatment of patients with acute coronary syndromes in the Netherlands in 2000-2001; a comparison with other European countries and with the guidelines]
    R Nieuwlaat
    Academisch Ziekenhuis, afd Cardiologie, Postbus 5800, 6202 AZ Maastricht
    Ned Tijdschr Geneeskd 148:1878-82. 2004
  2. ncbi Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, P Debyelaan 25, PO Box 5800, Maastricht 6202AZ, Maastricht, The Netherlands
    Eur Heart J 26:2422-34. 2005
  3. ncbi Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    Eur Heart J 27:3018-26. 2006
  4. ncbi Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    Am Heart J 153:1006-12. 2007
  5. ncbi Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort
    Bob Weijs
    Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, PO Box 5800, Maastricht 6202 AZ, The Netherlands
    Europace 14:184-90. 2012
  6. ncbi Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    Eur Heart J 29:1181-9. 2008
  7. ncbi A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey
    Ron Pisters
    Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Chest 138:1093-100. 2010
  8. ncbi Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    J Am Coll Cardiol 53:1690-8. 2009
  9. ncbi Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey
    Ron Pisters
    Department of Cardiology, Maastricht University Medical Centre, The Netherlands
    Europace 14:666-74. 2012
  10. ncbi Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey
    Cees B De Vos
    Department of Cardiology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Eur Heart J 29:632-9. 2008

Collaborators

Detail Information

Publications18

  1. ncbi [Treatment of patients with acute coronary syndromes in the Netherlands in 2000-2001; a comparison with other European countries and with the guidelines]
    R Nieuwlaat
    Academisch Ziekenhuis, afd Cardiologie, Postbus 5800, 6202 AZ Maastricht
    Ned Tijdschr Geneeskd 148:1878-82. 2004
    ....
  2. ncbi Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, P Debyelaan 25, PO Box 5800, Maastricht 6202AZ, Maastricht, The Netherlands
    Eur Heart J 26:2422-34. 2005
    ..To describe atrial fibrillation (AF) management in member countries of the European Society of Cardiology (ESC) and to verify cardiology practices against guidelines...
  3. ncbi Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    Eur Heart J 27:3018-26. 2006
    ....
  4. ncbi Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    Am Heart J 153:1006-12. 2007
    ..What consequences does guideline-deviant antithrombotic treatment have in daily practice?..
  5. ncbi Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort
    Bob Weijs
    Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, PO Box 5800, Maastricht 6202 AZ, The Netherlands
    Europace 14:184-90. 2012
    ..An age of 60 years is often used as cut-off for the diagnosis of idiopathic atrial fibrillation (AF). We investigated the importance of age and atrial size in patients with idiopathic AF and AF patients with isolated hypertension...
  6. ncbi Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    Eur Heart J 29:1181-9. 2008
    ..To gain insight in the prognosis and treatment of atrial fibrillation (AF) patients during 1-year follow-up in the Euro Heart Survey (EHS) on AF...
  7. ncbi A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey
    Ron Pisters
    Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Chest 138:1093-100. 2010
    ..We aimed to develop a practical risk score to estimate the 1-year risk for major bleeding (intracranial, hospitalization, hemoglobin decrease > 2 g/L, and/or transfusion) in a cohort of real-world patients with AF...
  8. ncbi Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    J Am Coll Cardiol 53:1690-8. 2009
    ..Our aim was to identify shortcomings in the management of patients with both atrial fibrillation (AF) and heart failure (HF)...
  9. ncbi Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey
    Ron Pisters
    Department of Cardiology, Maastricht University Medical Centre, The Netherlands
    Europace 14:666-74. 2012
    ..We aim to describe present-day cardioversion of AF and identify characteristics associated with immediate and long-term outcome...
  10. ncbi Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey
    Cees B De Vos
    Department of Cardiology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Eur Heart J 29:632-9. 2008
    ..To investigate the clinical characteristics, management, and outcome of patients with paroxysmal atrial fibrillation (AF) associated with autonomic triggers...
  11. ncbi Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
    Robby Nieuwlaat
    Department of Cardiology, University Hospital Maastricht, P Debyelaan 25, PO Box 5800, Maastricht 6221AZ, The Netherlands
    Eur Heart J 29:915-22. 2008
    ..To assess the relation between the atrial fibrillation (AF) subtype and thrombo-embolic events...
  12. ncbi Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms
    Ron Pisters
    Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Semin Thromb Hemost 35:554-9. 2009
    ....
  13. ncbi Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis
    Cees B De Vos
    Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands
    J Am Coll Cardiol 55:725-31. 2010
    ..We investigated clinical correlates of atrial fibrillation (AF) progression and evaluated the prognosis of patients demonstrating AF progression in a large population...
  14. ncbi Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients
    Bob Weijs
    Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht CARIM, P O Box 5800, 6202 AZ Maastricht, The Netherlands
    Eur Heart J 32:2555-62. 2011
    ..However, VKA use has been associated with increased vascular calcification. The aim of this study was to investigate the contribution of VKA use to coronary artery calcification in low-risk AF patients...
  15. ncbi The Euro Heart Survey program: what's in it for nurses?
    Mattie Lenzen
    Department of Cardiology, Clinical Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
    Prog Cardiovasc Nurs 22:166-8. 2007
  16. ncbi Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation
    Nikolaos Dagres
    University of Athens, Second Cardiology Department, Attikon University Hospital, Athens, Greece
    J Am Coll Cardiol 49:572-7. 2007
    ..This study sought to investigate gender-related differences in patients with atrial fibrillation (AF) in Europe...
  17. ncbi Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction
    Ron T van Domburg
    Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    J Am Coll Cardiol 46:15-20. 2005
    ..The goal of this research was to clarify whether the benefit of reperfusion therapy for myocardial infarction was sustained long-term and to assess the gain in life expectancy by reperfusion therapy...
  18. ncbi Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation
    Anna Ringborg
    Europace 10:403-11. 2008
    ..To estimate costs of admission and costs incurred on an annual basis by patients with atrial fibrillation (AF) in Greece, Italy, Poland, Spain, and the Netherlands...